Copea Pharma Limited in Liverpool, L24 1YA

Description

Data updated on: 01-11-2023

Registered as 08592240 eleven years ago, Copea Pharma Limited was set up as a Private Limited Company. The firm's present office address is 25 Compass West Spindus Road, Speke Hall Industrial Estate Liverpool. The name of the firm was replaced in 2020 to Copea Pharma Limited. The company former registered name was Geryon Pharma. This business's SIC and NACE codes are 21100 which stands for Manufacture of basic pharmaceutical products. Copea Pharma Ltd filed its account information for the financial period up to 2022-07-31. The firm's most recent confirmation statement was filed on 2023-06-30.

In this particular business, the full range of director's obligations have so far been fulfilled by Mark D. who was assigned this position eleven years ago. This business had been managed by Pamela T. up until 2020. What is more another director, namely Karl F. quit in 2015.

Mark D. is the individual with significant control over this firm, has substantial control or influence over the company, owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Previous company's names
Copea Pharma Limited 2020-03-20
Geryon Pharma Limited 2013-07-01

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-07-31	2021-07-31	2022-07-31	2023-07-31
Currency
Net Worth	-45 972	9 499	63 607

Balance Sheet
Cash Bank On Hand			128 476	177 987	130 186	176 935	140 161	228 090	67 182	51 597
Current Assets	40 644	73 212	153 749	256 248	301 671	300 056	255 933	467 198	366 096	353 189
Debtors	17 954	51 590	25 273	78 261	171 485	123 121	115 772	239 108	298 914	301 592
Net Assets Liabilities							129 815	303 377	287 596	256 805
Property Plant Equipment			36 558	29 110	26 639	51 891	33 421	6 207	15 222	19 095
Cash Bank In Hand	22 690	21 622	128 476
Other Debtors				22 297	23 700	24 730
Tangible Fixed Assets	7 672	21 208	36 558

Capital & Reserves
Called Up Share Capital	300	300	300
Profit Loss Account Reserve	-46 272	9 199	63 307
Shareholder Funds	-45 972	9 499	63 607

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment			26 157	44 579	64 909	93 293	114 625	30 067	35 504	39 856
Additions Other Than Through Business Combinations Property Plant Equipment								499	21 002	8 225
Average Number Employees During Period				1	1		2	2	2	-2
Creditors			126 700	176 561	198 254	166 992	159 539	170 028	64 555	96 312
Depreciation Rate Used For Property Plant Equipment								25	25
Disposals Decrease In Depreciation Impairment Property Plant Equipment								100 578	3 276
Disposals Property Plant Equipment								112 271	6 550
Future Minimum Lease Payments Under Non-cancellable Operating Leases									-127 599	-69 709
Increase From Depreciation Charge For Year Property Plant Equipment				18 422	20 330	28 384		16 020	8 713	4 352
Net Current Assets Liabilities	-53 644	-2 580	27 049	79 687	103 417	133 064	96 394	297 170	301 541	256 877
Property Plant Equipment Gross Cost			62 715	73 689	91 548	145 184	148 046	36 274	50 726	58 951
Total Assets Less Current Liabilities	-45 972	9 499	63 607	108 797	130 056	184 955	129 815	303 377	316 763
Advances Credits Directors						11 655	11 655	11 655	9 862
Creditors Due Within One Year	94 288	75 792	126 700
Finance Lease Liabilities Present Value Total			3 207
Number Shares Allotted	3	3	3
Other Creditors			101 259	133 103	117 714	129 097
Other Taxation Social Security Payable			22 234	24 593	30 756	8 413
Par Value Share	1	1	1
Tangible Fixed Assets Additions	10 229	9 285	31 029
Tangible Fixed Assets Cost Or Valuation	10 229	19 514	62 715
Tangible Fixed Assets Depreciation	2 557	7 435	26 157
Tangible Fixed Assets Depreciation Charged In Period	2 557	4 878	15 679
Total Additions Including From Business Combinations Property Plant Equipment				10 974	17 859	53 636
Trade Creditors Trade Payables				18 865	49 784	29 482
Trade Debtors Trade Receivables			25 273	55 964	147 785	98 391
Value Shares Allotted	300	300	300

Company staff

Mark D.

Role: Director

Appointed: 01 July 2013

Latest update: 19 February 2024

People with significant control

Mark D.

Notified on 30 June 2016

Nature of control:

1/2 or less of voting rights

substantial control or influence

1/2 or less of shares

Pamela T.

Notified on 30 June 2016

Ceased on 6 March 2020

Nature of control:

1/2 or less of voting rights

substantial control or influence

1/2 or less of shares

Accounts Documents

Account next due date	30 April 2024
Account last made up date	31 July 2022
Confirmation statement next due date	14 July 2024
Confirmation statement last made up date	30 June 2023

Annual Accounts 31 March 2015
Start Date For Period Covered By Report	01 August 2013
End Date For Period Covered By Report	31 July 2014
Date Approval Accounts	31 March 2015
Annual Accounts 28 April 2016
Start Date For Period Covered By Report	01 August 2014
End Date For Period Covered By Report	31 July 2015
Date Approval Accounts	28 April 2016
Annual Accounts 3 March 2017
Start Date For Period Covered By Report	01 August 2015
End Date For Period Covered By Report	31 July 2016
Date Approval Accounts	3 March 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2018
End Date For Period Covered By Report	31 July 2019
Annual Accounts
Start Date For Period Covered By Report	01 August 2018
End Date For Period Covered By Report	31 July 2019
Annual Accounts
Start Date For Period Covered By Report	01 August 2018
End Date For Period Covered By Report	31 July 2019
Annual Accounts
Start Date For Period Covered By Report	01 August 2018
End Date For Period Covered By Report	31 July 2019

Copea Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mark D.

Pamela T.

Karl F.

People with significant control

Mark D.

Pamela T.

Accounts Documents

Company filings

Filing category

Additional Information

HQ address,
2014

Address:

Post code:

City / Town:

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies

Copea Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mark D.

Pamela T.

Karl F.

People with significant control

Mark D.

Pamela T.

Accounts Documents

Company filings

Filing category

Additional Information

HQ address, 2014

Address:

Post code:

City / Town:

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies

HQ address,
2014